Sarepta Therapeutics Inc (SRPT)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 2,579,330 | 2,557,860 | 2,604,100 | 2,485,200 | 1,468,910 |
| Total current liabilities | US$ in thousands | 653,659 | 619,604 | 452,733 | 416,026 | 264,767 |
| Current ratio | 3.95 | 4.13 | 5.75 | 5.97 | 5.55 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $2,579,330K ÷ $653,659K
= 3.95
The current ratio of Sarepta Therapeutics Inc has shown a declining trend over the past five years, decreasing from 5.55 in 2019 to 3.95 in 2023. This indicates that the company's current assets may not be as sufficient in covering its current liabilities as they were previously. Despite the decline, the current ratio remains above 1.0 for all years, suggesting that the company still has an adequate level of current assets to meet its short-term obligations. However, investors and creditors may want to monitor this trend closely to ensure the company's liquidity position remains stable.
Peer comparison
Dec 31, 2023